Si-bone vs Treace Medical Concepts
Si-bone and Treace Medical Concepts are similar in size: $201m and $213m of revenue in their latest fiscal years. Si-bone grew faster (20.2% against 1.6%). Si-bone kept more of each dollar of sales as profit: a net margin of -9.4% against -27.7%. Si-bone carries less debt relative to equity (20.3% against 68.7%).
| Latest fiscal year | Si-boneSIBN, 2025 | Treace Medical ConceptsTMCI, 2025 |
|---|---|---|
| Revenue | $201m | $213m |
| Revenue growth | 20.2% | 1.6% |
| Net income | −$18.9m | −$59.0m |
| Operating margin | -11.1% | -25.5% |
| Net margin | -9.4% | -27.7% |
| Return on equity | -11.0% | -58.9% |
| Free cash flow | −$9.1m | −$29.5m |
| Cash | $42.2m | $10.7m |
| Total debt | $36.0m | $60.0m |
| Debt to equity | 20.3% | 68.7% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 376 | 450 |
| Market value | $1.05bn | $278m |
| Price vs our value range | — | — |
| Moat score | 27 (Weak) | 30 (Weak) |
| Insider trades, 12 months | 0 buys, 106 sales | 14 buys, 0 sales |